← FDA DRUG APPROVALS

FDA ANDA · ANDA074166

TOPOSAR

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA074166
TYPE
ANDA
ORIGINAL APPROVAL
1995-02-27
LATEST ACTION
1999-08-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TOPOSARDiscontinued
ETOPOSIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

1999-08-27Labeling · Supplement 1AP
1995-02-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →